Featured Post
Why Automation Is Growing in Non-Sterile Compounding in the USA
Non-sterile compounding automation is reshaping how independent pharmacies in the United States operate. Driven by a convergence of regulatory demands, workforce constraints, and rising patient demand for personalized dosing, compounding pharmacy automation has moved from a niche consideration to a strategic priority for private pharmacies looking to remain competitive and compliant in 2026 and beyond.
Compounding HRT - Hormone Replacement Therapy
Personalized Vaginal Hormone Therapy – We’re coming to you from Texas, where we’re compounding something truly exciting: personalized vaginal tablets designed specifically for patients experiencing menopause symptoms.
The Pros and Cons of Personalized Medicine: Can Compounding Help Overcome the Barriers?
Explore personalized medicine benefits and barriers. Learn how modern compounding technology makes custom treatments affordable and accessible for healthcare facilities.
The Basics of Personalized Medicine: Why Automated Compounding Is Key to Its Future
Learn how automated compounding systems enable personalized medicine to scale from 1% to 10% of prescriptions through precision, quality control, and efficiency.
The Medicine Maker Presents CurifyLabs PharmaPrinter Aurum
Discover PharmaPrinter Aurum, the latest innovation in automated pharmaceutical compounding, presented by CurifyLabs and The Medicine Maker.
NEWS FROM SWEDEN: First delivery of extemporaneous medicinal products manufactured using 3D technology
https://press.apl.se/posts/pressreleases/forsta-leveransen-av-extemporelakemedel-tillv
Joseph Shoyoye, One Pharmacy
Discover how Joseph Shoyoye of One Pharmacy leverages automation to enhance precision, consistency, and efficiency in modern pharmaceutical compounding.
CurifyLabs Unveils Next Gen 3D Printer for Scalable Plug-and-Play Pharmaceutical Compounding
CurifyLabs PharmaPrinter Aurum
Adam Kemp joins CurifyLabs as Sales Director, United States!
Adam Kemp joins CurifyLabs coming from PCCA
The Medicine Maker Presents CurifyLabs' New Excipient Base: CuraBlend®Vet
Discover CuraBlend®Vet, CurifyLabs' new excipient base for stress-free veterinary compounding with broad compatibility and high palatability for pets. Now available with digital integration.
Press Release: CurifyLabs Launches CuraBlend®Vet, Bringing Breakthrough 3D-Printed, Personalized Medicines to Pets
CurifyLabs introduces CuraBlend®Vet, a 3D-printed, flavored gel tablet for pets, improving adherence and simplifying medication administration with personalized dosages.